Back to top Open menu arrow
Purchase PDF

Save Save

Cite Cite

Reprints
Sections
METHODS RESULTS DISCUSSION CONCLUSION Clinical Points
Primary Care Companion for CNS Disorders Primary Care Companion for CNS Disorders

The Primary
Care Companionfor CNS Disorders
Access icon

Systematic Review October 12, 2023

Cognition in Schizophrenia: A Systematic Review of Wechsler Adult Intelligence Scale Studies

; ; ; ; ; ;

Prim Care Companion CNS Disord 2023;25(5):22r03456

ABSTRACT

Objective: To critically analyze the evidence regarding changes in verbal and performance intelligence quotient (IQ) in patients with schizophrenia.

Data Sources: An English-language–only search was conducted in the PubMed, Cochrane Library, and LILACS databases for articles with study objectives that included Wechsler Adult Intelligence Scale (WAIS) assessment of cognitive functions in patients with schizophrenia. Descriptors were defined based on Medical Subject Headings, where associations of psychotic disorders related to the schizophrenia spectrum were suggested, as well as the “Wechsler Scales” descriptor. The search was conducted in November 2022 with no restriction on the date of publication to select studies that used any of the WAIS editions.

Study Selection: Articles that met the inclusion criteria were selected after title and summary identification and full-text review.

Results: A total of 28 articles were identified. All studies presented total IQ scores, but only 20 showed results for verbal IQ (n = 20) or performance IQ (n = 19). Analyzed data indicated patients had average performance on verbal comprehension features but low average performance on perceptual reasoning, working memory, and processing speed indices.

Conclusions: Executive function deficits were found in the analyzed studies, which reflect difficulties in planning and impulse control—characteristics present in the diagnosis of schizophrenia. The identification of this neuropsychological functioning contributes to the understanding of the cognitive dynamics found in schizophrenia and may help in early diagnosis, reinforcing the hypothesis that cognitive performance may be one of the indicators of psychopathologic expression.

Prim Care Companion CNS Disord 2023;25(5):22r03456

Author affiliations are listed at the end of this article.

  1. American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders - DSM-5. Fifth Edition. Washington: American Psychiatric Association; 2013.
  2. Sideli L, Mule A, La Barbera D, et al. Do child abuse and maltreatment increase risk of schizophrenia? Psychiatry Investig. 2012;9(2):87–99. PubMed CrossRef
  3. Ruby E, Polito S, McMahon K, et al. Pathways associating childhood trauma to the neurobiology of schizophrenia. Front Psychol Behav Sci. 2014;3(1):1–17. PubMed
  4. Volk DW, Lewis DA. Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease. 5th ed. Academic Press; 2014.
  5. Nuechterlein KH, Barch DM, Gold JM, et al. Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004;72(1):29–39. PubMed CrossRef
  6. Callicott JH, Mattay VS, Bertolino A, et al. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex. 1999;9(1):20–26. PubMed CrossRef
  7. Heinrichs RW. The primacy of cognition in schizophrenia. Am Psychol. 2005;60(3):229–242. PubMed CrossRef
  8. Kudo N, Yamamori H, Ishima T, et al. Plasma levels of soluble tumor necrosis factor receptor 2 (sTNFR2) are associated with hippocampal volume and cognitive performance in patients with schizophrenia. Int J Neuropsychopharmacol. 2018;21(7):631–639. PubMed CrossRef
  9. Lin YT, Liu CM, Chiu MJ, et al. Differentiation of schizophrenia patients from healthy subjects by mismatch negativity and neuropsychological tests. PLoS One. 2012;7(4):e34454. PubMed CrossRef
  10. Lezak MD, Howieson DB, Loring DW, et al. Neuropsychological Assessment. 5th ed.  Oxford University Press; 2014.
  11. Michel NM, Goldberg JO, Heinrichs RW, et al. WAIS-IV profile of cognition in schizophrenia. Assessment. 2013;20(4):462–473. PubMed CrossRef
  12. Wechsler D. Wechsler Adult Intelligence Scale: Technical and Interpretive Manual. 4th ed. San Antonio, TX: Psychological Corporation; 2008.
  13. Gold JM, Hurt SW. The effects of haloperidol on thought disorder and IQ in schizophrenia. J Pers Assess. 1990;54(1-2):390–400. PubMed
  14. Goldman RS, Axelrod BN, Tandon R, et al. Spurious WAIS-R cholinergic profiles in schizophrenia. Clin Neuropsychol. 1993;7(2):171–178. PubMed CrossRef
  15. Condray R, van Kammen DP, Steinhauer SR, et al. Language comprehension in schizophrenia: trait or state indicator? Biol Psychiatry. 1995;38(5):287–296. PubMed CrossRef
  16. Fujii DE, Ahmed I, Jokumsen M, et al. The effects of clozapine on cognitive functioning in treatment-resistant schizophrenic patients. J Neuropsychiatry Clin Neurosci. 1997;9(2):240–245. PubMed CrossRef
  17. Hawkins KA, Sullivan TE, Choi EJ. Memory deficits in schizophrenia: inadequate assimilation or true amnesia? findings from the Wechsler Memory Scale–revised. J Psychiatry Neurosci. 1997;22(3):169–179. PubMed
  18. Mortimer AM, Bowen K. Measuring IQ in schizophrenia research: an update of the Quick Test in estimating IQ decline. Cogn Neuropsychiatry. 1999;4(2):81–88. PubMed CrossRef
  19. Ilonen T, Taiminen T, Lauerma H, et al. Impaired Wisconsin card sorting test performance in first-episode schizophrenia: resource or motivation deficit? Compr Psychiatry. 2000;41(5):385–391. PubMed CrossRef
  20. Egan MF, Goldberg TE, Gscheidle T, et al. Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry. 2001;50(2):98–107. PubMed CrossRef
  21. Baron K, Hays JR. Characteristics of readmitted psychiatric inpatients. Psychol Rep. 2003;93(1):235–238. PubMed CrossRef
  22. Zakzanis KK, Andrikopoulos J, Young DA, et al. Neuropsychological differentiation of late-onset schizophrenia and dementia of the Alzheimer’s type. Appl Neuropsychol. 2003;10(2):105–114. PubMed CrossRef
  23. Nakano H, Terao T, Iwata N, et al. Symptomatological and cognitive predictors of insight in chronic schizophrenia. Psychiatry Res. 2004;127(1-2):65–72. PubMed CrossRef
  24. Hori H, Noguchi H, Hashimoto R, et al. Antipsychotic medication and cognitive function in schizophrenia. Schizophr Res. 2006;86(1-3):138–146. PubMed CrossRef
  25. Maeda K, Kasai K, Watanabe A, et al. Effect of subjective reasoning and neurocognition on medication adherence for persons with schizophrenia. Psychiatr Serv. 2006;57(8):1203–1205. PubMed CrossRef
  26. Mo S, Su Y, Chan RC, et al. Comprehension of metaphor and irony in schizophrenia during remission: the role of theory of mind and IQ. Psychiatry Res. 2008;157(1-3):21–29. PubMed CrossRef
  27. Stefanopoulou E, Lafuente AR, Saez Fonseca JA, et al. Insight, global functioning and psychopathology amongst in-patient clients with schizophrenia. Psychiatr Q. 2009;80(3):155–165. PubMed CrossRef
  28. Ozguven HD, Oner O, Baskak B, et al. Theory of mind in schizophrenia and Asperger’s syndrome: relationship with negative symptoms. Klinik Psikofarmakol Bulteni. 2010;20(1):5–13. PubMed CrossRef
  29. Lu W, Zhang C, Yi Z, et al. Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia. J Mol Neurosci. 2012;47(3):505–510. PubMed CrossRef
  30. Rapp EK, White-Ajmani ML, Antonius D, et al. Schizophrenia comorbid with panic disorder: evidence for distinct cognitive profiles. Psychiatry Res. 2012;197(3):206–211. PubMed CrossRef
  31. Zhu X, Gu H, Liu Z, et al. Associations between TCF4 gene polymorphism and cognitive functions in schizophrenia patients and healthy controls. Neuropsychopharmacology. 2013;38(4):683–689. PubMed CrossRef
  32. Kao YC, Liu YP, Lien YJ, et al. The influence of sex on cognitive insight and neurocognitive functioning in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2013;44:193–200. PubMed CrossRef
  33. Fukumoto M, Hashimoto R, Ohi K, et al. Relation between remission status and attention in patients with schizophrenia. Psychiatry Clin Neurosci. 2014;68(3):234–241. PubMed CrossRef
  34. Dang J, Zhang J, Guo Z, et al. A pilot study of iPad-assisted cognitive training for schizophrenia. Arch Psychiatr Nurs. 2014;28(3):197–199. PubMed CrossRef
  35. El-Missiry A, Elbatrawy A, El Missiry M, et al. Comparing cognitive functions in medication adherent and non-adherent patients with schizophrenia. J Psychiatr Res. 2015;70:106–112. PubMed CrossRef
  36. Nilsson BM, Holm G, Ekselius L. Karolinska scales of personality, cognition and psychotic symptoms in patients with schizophrenia and healthy controls. Nord J Psychiatry. 2016;70(1):53–61. PubMed CrossRef
  37. Liang S, Deng W, Wang Q, et al. Performance of verbal fluency as an endophenotype in patients with familial versus sporadic schizophrenia and their parents. Sci Rep. 2016;6(1):32597. PubMed CrossRef
  38. Krukow P, Karakuła-Juchnowicz H, Juchnowicz D, et al. Processing speed is associated with differences in IQ and cognitive profiles between patients with schizophrenia and their healthy siblings. Nord J Psychiatry. 2017;71(1):33–41. PubMed CrossRef
  39. Moher D, Liberati A, Tetzlaff J, et al; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. PubMed CrossRef
  40. Wang Q, Chan R, Sun J, et al. Reaction time of the continuous performance test is an endophenotypic marker for schizophrenia: a study of first-episode neuroleptic-naive schizophrenia, their non-psychotic first-degree relatives and healthy population controls. Schizophr Res. 2007;89(1-3):293–298. PubMed CrossRef
  41. Islam MA, Habtewold TD, van Es FD, et al; GROUP Investigators. Long-term cognitive trajectories and heterogeneity in patients with schizophrenia and their unaffected siblings. Acta Psychiatr Scand. 2018;138(6):591–604. PubMed CrossRef
  42. Heinrichs RW, Ammari N, Miles AA, et al. Cognitive performance and functional competence as predictors of community independence in schizophrenia. Schizophr Bull. 2010;36(2):381–387. PubMed CrossRef
  43. Hu M, Chen J, Li L, et al. Semantic fluency and executive functions as candidate endophenotypes for the early diagnosis of schizophrenia in Han Chinese. Neurosci Lett. 2011;502(3):173–177. PubMed CrossRef

About the Authors

Buy PDF for $40

Please sign in or purchase this PDF for $40.

Save Save

Cite Cite

Vol 27 • 2025 • Number 3

Read the Current Issue

Original Research

Conflict Mediation by CBT

Systematic Review

Psychiatric Adverse Effects of Hydroxychloroquine

Review Article

Efficacy of GLP-1 Agonists in Mental Disorders

Rounds in the General Hospital

Time-Limited Teaching of Psychiatry to Medical Students

Rounds in the General Hospital

Multimodal Approaches to Pain Management

Rounds in the General Hospital

Sequelae of Adverse Childhood Experiences
View current Issue

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe